Our Friend and advisor Prof Baran from Scripps published the following in JOC: Aiming for the Ideal Synthesis, doi: 10.1021/jo1006812. In which he makes the following statement "Finally, scalable syntheses of complex natural products help debunk the myth that such compounds are not economically viable targets in the pharmaceutical industry". With this statement he is so far from the mark it is not true. A 50 step synthesis with an overall yield of 5 - 10% is just not realistic, 0.05% may be better. This means tons of SM must be converted down the line. I know, I have done it!
I think he has absolutely no idea what development of a drug substance entails. Does anyone here have an opinion? I would be glad to hear it
Baran gives many examples of "ideal synthesis" here is one he quotes from Heathcock:

He tries to redefine an idea from Hendrickson %ideality = (no. of construction reactions) + (no. of strategic redox reactions) all divided by the total number of steps, the result multiplied by 100.
I should add that each purification step, chromatography, crystallisation, distillation also counts as a "reaction step"
From an industrial standpoint this synthesis from Heathcock has several "faults"
1 low temperature reactions at least 4
2 DIBAL-H in my experience reduces esters directly to the alcohols unless you do it at -90 - -100°C 3 MsCl is a big no no due to toxicity issues (MAC in air 1ppb) especially in the GMP step thus very careful analysis is required to ensure none is carried through to the final compound.
4 two compounds containing sensitive aldehyde groups.
5 Methylamine, toxicity problems, sensitiser, waste disposal etc
6 The compound must be an acetic acid salt although this is not discussed. This would be an expensive synthesis. I don't know how many compounds are crystalline, I would guess not many, making handling difficult.
I could go on and on.
So my point still remains: has absolutely no idea what development of a drug substance entails.
I can send a copy of the paper if anyone wants it.